chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pregnant since November 2020; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant since November 2020) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 16-Jul-2021. On 20-Nov-2020, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant since November 2020). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant since November 2020) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. List of concomitant medication were not reported .   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Internal review on 21-JUL-2021 resulted in updates of Due date , Birth type, Fetal outcome .
A report was received from a healthcare professional on 16/Jan/2007 concerning a 20 year old female vaccinee. No details were provided regarding the vaccinee's medical history or concomitant medications. On 15/Jan/2007 the vaccinee received a dose of Fluvirin intramuscularly. The same day, the vaccinee experienced swelling at the injection site with redness and myalgia in the upper arm in the area where the dose was administered. Further information will be requested. A Follow-up report was received from a healthcare professional on 13/Apr/2007. The vaccinee has been confirmed as a 21-year-old female. No details were provided regarding the vaccinee's medical history or concomitant medications. On 10/Jan/2007, the vaccinee was administered Fluvirin, intramuscularly in her deltoid. On 11/Jan/2007 the vaccinee experienced severe pain in her left upper arm and decreased range of movement at her left shoulder. The vaccinee also experienced swelling in her upper arm. The vaccinee was treated with Tylenol, Benadryl, Medrol Dosepack with ice, rest and elevation. The symptoms resolved on 17/Jan/2007. The reporter considers the event to be serious due to disability. No further information is expected.
Pt had a fever and pain at the top of her arm into her neck. Her arm was so sore and swollen she could not bend it.
4 hours after the vaccine, a dull headache; restless sleep/insomnia throughout the night. 24 hours after the vaccine two rashes appeared (upper back behind left shoulder; and on the underside of left breast); they are suspected as herpes zoster. Rx is 800mg acylovire 5x/day for 7 days with advil or tylenol for pain, caladryl for itching and ice.  Pain is localized and severe. No fever.
On 2/21/03 at 12 noon L uper arm shoulder region began itching on 2/22/03 at 8am, L deltoid regions was red, hot and swollen and could with bumps. Saw MD above at ER, prescribed Benadryl liquid and po antibiotics area is now only blotchy with few bumps. Cellulitis.
Patient presented to the ER after a pre-syncopal episode she experienced at grocery store. She  stated she had a cough for last 4 days.  The patient tested positive for COVID-19. Troponin was elevated.  Her blood pressure was on the high side. The patient was admitted to the hospital under observation with ER.   Near syncope. LIKELY 2ND TO COVID19.  Blood pressure poorly controlled.  We will add Norvasc.  Continue Cardura 4 mg.  Increase lisinopril to 20 mg daily.  Monitor blood pressure closely.at home, Rx was given for Bp kit   DVT prophylaxis.  Procalcitonin was negative, she received monoclonal antibodies infusion.  Patient was discharged on room air after being cleared by cardiology.  No fever,  No chest pain.  No shortness of breath.
Fever NOS on 2022-02-02, Postvaccination fever on 2022-02-02.
17OCT94 sore throat by evening of flu shot; 18OCT94 cold, sniffles, cough, felt feverish but no temp; 19OCCT94 h/a, very tired; 23OCT94 stiff neck, shoulder pain, laryngitis; for about a month felt problems & believe that VitC tablets help
Shingles 23 days after 1st dose - Shingles was across abdomen on right side across to middle of spine.  Shingles and Severe Nerve pain lasted approximately 30 days - scarring still visible and a small area in middle of spine still has nerve pain. Saw my doctor 3 days after first signs and was given medication to treat all symptoms.
During a 15 minute walk, my heart started hurting. As I walked, it felt worse the point where I decided to file this report. I would label the pain scale as a 6 out of 10. At the same time, i began feeling dizzy.  My breathing had not changed, but my regular breathing did not feel adequate in getting enough oxygen in my body. I felt disoriented and had to sit down for several minutes to recover. I went to the gym, where my cardio workout had to be cancelled, since I could not walk on the treadmill without feeling sick. This is the worst I've ever felt in response to a flu shot, and I try to take flu shots annually.
joint pain; bone pain; muscle pain; tiredness; fever; feeeling of warm from inside out the body; irritation in the throat and the sensation of a foreign body in the throat; irritation in the throat and the sensation of a foreign body in the throat; nausea; headache; eye pain; general discomfort; This is a spontaneous report from a contactable consumer (patient). A 57-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and batch no, lot number and expiration date was not reported), first dose via an unspecified route of administration on 18Mar2021 (at the age of 57 year) as for covid-19 immunization. Medical history included cancer (patient was cancer survivor), ongoing osteoporosis. Concomitant medications included ergocalciferol (VIT D) and calcium taken for osteoporosis. Since vaccination, on 18Mar2021, patient has been presenting with joint pain, bone pain, muscle pain, tiredness, fever and the feeling of warm from inside out the body, throat irritation and the feeling of foreign body in the throat, nausea, headache, eyes pain and general discomfort. Patient reported she has been taking Tylenol at nights to manage the symptoms but as the evening arrives, symptoms are coming back and 8 days after vaccination has not disappeared. Patient reported she has not gone to the physician for management of prior symptoms. Therapeutic measures were taken as a result of all events and included treatment with Tylenol. The outcome of the events was unknown.   No follow-up attempts are possible;information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse and refers to a patient of unknown age and gender. There was no information about patient's concurrent conditions, medical history or concomitant medications. On an unknown date, the patient was vaccinated with a dose of improperly stored VARIVAX lot # N015475 and expiration date of 18-MAY-2018, (route of administration and anatomical location were not reported) for prophylaxis, which was stored in the range of -14 Celsius degrees to -10 Celsius degrees for 30 minutes. Previous temperature excursion was reported as -14 Celsius degrees to -10 Celsius degrees for 12 hours and 30 minutes. The vaccine was reconstituted with properly stored DILUENT MRK. No adverse effects were reported. No digital data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1808USA003614: US-009507513-1808USA003653.
Long hauler, Long haul symptoms and about killed him; This spontaneous case was reported by a consumer and describes the occurrence of POST-ACUTE COVID-19 SYNDROME (Long hauler, Long haul symptoms and about killed him) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced POST-ACUTE COVID-19 SYNDROME (Long hauler, Long haul symptoms and about killed him). At the time of the report, POST-ACUTE COVID-19 SYNDROME (Long hauler, Long haul symptoms and about killed him) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On Monday January 4th I received my Covid-19 vaccine at work, at 410pm. That evening went uneventful. The following day, Tuesday January 5th I woke up with a sore right arm and a slight headache. The headache increased in intensity throughout the day, developing also body aches and a fever of 100.4. The symptoms seemed to improve slightly after taking Tylenol.  The next day, Wednesday January 6th I felt much better, the body aches were almost gone, I had no fever and no headache. When I got home from work I noticed hives all over my arms, anterior and posterior neck - going into the hairline, face, especially around my mouth, chest, abdomen, upper and lower back. The affected areas were itchy and I also felt a slight burning/stinging sensation on my neck. Even though I did not notice any hives on my legs, my right ankle was itchy, as well. I took Claritin 10 mg and I did not notice much difference. When I woke up today, Wednesday January 7th the hives were still present on my arms, chest, abdomen and back and they looked like dissipating.  It is currently 6:12 pm on January 7th and my hives are almost gone
pt recv vax 11JUL95 on 12JUL95 @ noon pt ate numerous spicy chicken wings; in ER by 3PM w/angioedema, difficulty breathing, red ears, hives; dx as allergic rxn to food;
Initial report received from a healthcare professional (pharmacist) on 09 OCTOBER 2014.  An 88-year-old female patient, had received a dose of FLUZONE HD, (batch number U5044AA, dose in series, route and site of vaccination were not reported) on 03 OCTOBER 2014. The patient's illness at the time of vaccination and pre-existing physician diagnosed allergies, birth defects and medical conditions were not reported. The patient's concomitant medications were not reported. On 08 OCTOBER 2014,  5 days after vaccination, the patient's "blood pressure was up" and felt like she was "going to have a heart attack". The patient was taken to hospital emergency room but "nothing was found".  Corrective treatment and laboratory details were not reported. At the time of this report, the patient outcome was unknown. Documents held by sender: none.
Ascending Body Aches, headaches, chills, mild audible expiratory wheezing 6hrs,  Albuterol Inhaler for wheezing, 600mg, Motrin,  500mg Tylenol.
10/6/08 VARIVAX *2 given in (R) arm + FLUMIST given intranasally.  10/7/08 (R) arm swollen + red & zero side of face/eyelid swollen + eye droopy.  Ice and Heat applied.  ADVIL given. zero fever.  10/8/08 arm still swollen, both sides of face swollen.  seen in office swelling/redness decreased o/c heat.  Applied  ice, BENADRYL.
Red spot in area of vaccine and arm very sore day of vaccination. Rash continued to spread. At time of reporting to RPh, patients husband said the whole body covered in red rash but no pain or itching.
Itchiness; Redness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Redness around injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PRAVASTATIN, AMLODIPINE, VALSARTAN, MONTELUKAST, CENTRUM SILVER +50 and COLECALCIFEROL (VIT D3) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Redness around injection site). The patient was treated with TRIAMCINOLONE at an unspecified dose and frequency; HALOBETASOL PROPIONATE at an unspecified dose and frequency; CYCLOSPORINE at an unspecified dose and frequency; METHOTREXATE SODIUM at an unspecified dose and frequency and FOLIC ACID at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Redness around injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-068925 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on 25-MAY-2021 contains non-significant information (contact information updated).
Chills, low-grade fever, muscle/body aches, headache experienced on 8/17/21.  Recovered from these symptoms. Muscle/body aches experienced on 8/18/21.  Recovered from these symptoms. Metallic taste in mouth present since 8/17/21 up until now, still currently experiencing it.
Intermittent pain (R) shoulder after 3rd HPV injection for less than 14 days. Continues at present time.
Patient expericing dull pain since second dose of COVID-19.  No sharp pain.  Pain comes & goes . Do not experience pain while sleeping.  Patient will visit doctor on Jun 07 2021.
This case was reported by a pharmacist via sales rep and described the occurrence of immobile in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced immobile (serious criteria GSK medically significant) and morbid thoughts. On an unknown date, the outcome of the immobile and morbid thoughts were unknown. It was unknown if the reporter considered the immobile and morbid thoughts to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. The reporter stated that the patient could not move and thought he was about to die after vaccination with the second dose of SHINGRIX. The reporter agreed to be contacted for follow up.
This prospective pregnancy report has been received from the patient's mother and referred to a 26-year-old female patient. The patient's relevant medical history, concurrent conditions, and concomitant therapies were not reported. In approximately 2002 (reported as "at age 11 or 12"), the patient was vaccinated with GARDASIL (dose, frequency, route of administration, lot number, and expiration date were not reported) for the prevention of human papillomavirus (HPV). On an unknown date, the patient became pregnant (last menstrual period (LMP) and estimated due date were not reported). On an unknown date, the patient was diagnosed by an unspecified method with an unspecified strain of HPV (Human papilloma virus test positive) as well as cervical cancer. The patient did not have any treatment for this, at the time of the report; however a biopsy would be performed after the patient's delivery to determine the course of treatment. At the time of this report, the outcome of papilloma viral infection and cervix carcinoma was unknown. The causality assessment between papilloma viral infection and cervix carcinoma with GARDASIL was unknown. Upon internal review, the event of cervix cancer was considered to be medically significant. Additional information has been requested.
On the night of the third dose, started out taking Tylenol, but was ineffective for the amount of pain, unable to sleep. Low grade fever. Went to the doctor and received an antibiotic and they assumed it was a UTI. Seemed to help the fever and was feeling better. Experienced lots of lower limb and back pain, taking Tylenol PM for aches and pains and to help sleep. By two weeks, I began to recover and by the third week I was feeling back to normal.
Caller reports his daughter received her first dose of GARDASIL 9 on 04AUG2015, and she has not received the second or third doses; Product lot number issue; No additional AE reported; This spontaneous report was received from a consumer, referring to his daughter, a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On 04-AUG-2015, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (strength, anatomical site of vaccination, and route of administration were not reported; lot number was reported as L010596 which was not valid for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). However, lot number L010596 was valid for quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), expiration date 06-APR-2017) as prophylaxis (product lot number issue), and she had not received the second or third doses (inappropriate schedule of product administration). No additional adverse effect (AE) reported.
Headaches, migraine, tiredness, feverish (chills, aches, hot skin), nauseous, food tastes odd, general feeling of unwell, anxiety, uptick in CRPS symptoms, clogged ears on day 12. Still have all symptoms on day 13.  Prescribed prednisone 20 mg, two pills a day for four days and one pill a day for four days
On 10/13/21 at approximately at 12:00 pm I was losing coordination of my right hand playing guitar. Then walking to bathroom tripped on right foot and fell against wall. I sat back down in chair for several hours thinking I would sleep it off. Woke up to go to bathroom and could not stand up, had no feeling or in my right arm and right leg with face numbness on right side. Called 911, they showed up and said my vitals are fine.  By the time I arrived at the hospital I lost all movement on my right arm and leg.  Had cat scan and several MRI a blood clot in brain stem was located. Treatment with aspirin an lovenox. Call doctor for more info.  I am confident this was an adverse reaction to this vaccine.
1 of 5 pts vaxed from the same lot# who exp a local rxn @ vax site;rxn described as enlarged, swollen, red & painful;exp diff moving vaxed arm x several days;recovered;
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 16-DEC-2016, the patient was vaccinated with an expired dose of PNEUMOVAX 23 lot # L022262, expiration date on 05-NOV-2016 (strength, dose number, route and anatomical location were not provided) for prophylaxis. No adverse events were reported. Additional information has been requested.
Fever of 102.6 and rising, major headache, body aches, couch, congestion, stopped up nose and ache in arm over the last 18 hours.
Persistent migraine, no taste for food, no appetite. This is continue after 4 weeks of the first vaccine dose, on 10/02/2021.
Hard lump and pain at injection site on day 7 after receiving first dose. Started feeling pain at the site on day 7, woke up on day 8 with a hard lump about 2 in. in diameter around injection site.
This spontaneous report was received from a physician and from a support services director via company representatives and refers to a patient of an unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 09-NOV-2015, the patient was vaccinated with a dose of an improperly stored GARDASIL 9 (strength: 0.5 ml) lot # L014198 and expiration date: 05-SEP-2017 (dose, anatomical location and route of administration were not reported). No adverse effects were reported. The dose of the vaccine was exposed to different temperature excursions (date unspecified): lasting for 48, and 120 hours, with the lowest recorded temperature of 33, and 34 degrees Fahrenheit (0.55, and 1.11 degrees Celsius) respectively. The vaccine was stored in a refrigerator. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
extreme tiredness, dizziness and body shakes for 3 days.  The day after the vaccine a cough developed, which has progressively worsened to today (4 weeks later).  CT scan on 12/9/2021 indicated pericardial effusion,  Symptoms continue to include coughing, shortness of breath and increased heart rate.
Info has been received from a physician concerning a retired female with allergy to cerivastatin (Baycol) which she experienced rhabdomyolysis who in 1997 was vaccinated with pneumococcal vaccine 23 polyvalent. On 08/15/2002, the pt was vaccinated with pneumococcal vaccine 23 polyvalent 0.5cc IM administered via the left deltoid (lot #1050) (invalid number provided). On 08/15/2002 the pt experienced redness at injection site, swelling at injection site and local inflammatory reaction. Unspecified medical attention was sought. The pt's redness at injection site and swelling at injection site and local inflammatory reaction persisted. Additional info has been requested.
Pt received 2nd Shingrix vaccine on 7/19/19. On 7/20/19 developed rash on arms and trunk. The pt also had a fever. The pt was seen in the office by Dr on 7/22/19. He determined the rash and fever were from the Shingrix vaccine. When the pt received her first Shingrix vaccine on 5/4/19 she ended up with pain and rash under her breast. She was seen in our office by NP on 5/6/19. NP stated it was contact dermatitis.
acute cerebellar ataxia w/rash & fever to 103 12 days post vax;
CHILLS; FEVER; PATIENT FAINTED IN BATHROOM; FAINTING RESULTED IN BLACK EYE; This spontaneous report received from a patient via a company representative concerned a patient of unknown sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 05-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported.  On the night of vaccination, 05-MAR-2021, the patient had chills and fever. The following day, the patient fainted in the bathroom which resulted in a black eye. At the time of this report, there were no reports of the previously mentioned adverse events. The patient would get a head x-ray to make sure everything was okay. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from patient fainted in bathroom, chills, and fever on MAR-2021, and the outcome of fainting resulted in black eye was not reported. The reporter causality between covid-19 vaccine ad26.cov2.s and chills, fever, patient fainted in bathroom was related. The reporter causality between covid-19 vaccine ad26.cov2.s and fainting resulted in black eye was possible. Company causality between covid-19 vaccine ad26.cov2.s and chills, fever, patient fainted in bathroom, fainting resulted in black eye was possible. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210318094-covid-19 vaccine ad26.cov2-fainting. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
pt recv vax in 1983 & exp elevated liver function studies until 1995;pt recovered;
Heart racing, fever, headache, body aches, chest tightness, coughing shortness of breath.